These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15096321)

  • 21. Management of thrombosis in cancer: primary prevention and secondary prophylaxis.
    Lee AY
    Br J Haematol; 2005 Feb; 128(3):291-302. PubMed ID: 15667530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of deep vein thrombosis in cancer patients.
    Lee AY
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-associated thrombosis: focus on extended therapy with dalteparin.
    Bick RL
    J Support Oncol; 2006 Mar; 4(3):115-20. PubMed ID: 16553136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low molecular weight heparins: the optimal treatment for venous thromboembolism.
    Daskalopoulos ME; Daskalopoulou SS; Liapis CD
    Curr Med Res Opin; 2004 Jul; 20(7):1001-5. PubMed ID: 15265244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis against venous thromboembolism after surgery for cancer.
    Moulias S; Bouchon JP; Meaume S
    N Engl J Med; 2002 Jul; 347(3):220; author reply 220. PubMed ID: 12124417
    [No Abstract]   [Full Text] [Related]  

  • 26. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low molecular weight heparins in cancer. Management and prevention of venous thromboembolism in patients with malignancies.
    ten Cate-Hoek AJ; Prins MH
    Thromb Res; 2008; 122(5):584-98. PubMed ID: 17996281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-molecular-weight heparin in oncology.
    Zacharski LR; Loynes JT
    Anticancer Res; 2003; 23(3C):2789-93. PubMed ID: 12926114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Warfarin versus low-molecular-weight heparin therapy in cancer patients.
    Zacharski LR; Prandoni P; Monreal M
    Oncologist; 2005 Jan; 10(1):72-9. PubMed ID: 15632254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of venous thromboembolism in surgical patients with breast cancer.
    Patiar S; Kirwan CC; McDowell G; Bundred NJ; McCollum CN; Byrne GJ
    Br J Surg; 2007 Apr; 94(4):412-20. PubMed ID: 17380560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
    Kher A; Bauersachs R; Nielsen JD
    Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous thromboembolism in the medically ill patient: a call to action.
    Bergmann JF; Kher A
    Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-molecular-weight heparins for the long-term treatment of cancer patients with venous thromboembolism.
    Prandoni P
    J Support Oncol; 2006 Mar; 4(3):127-8. PubMed ID: 16553138
    [No Abstract]   [Full Text] [Related]  

  • 35. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
    Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
    J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of venous thromboembolism in high-risk surgical and medical patients.
    Prandoni P; Sabbion P; Tanduo C; Errigo G; Zanon E; Bernardi E
    Semin Vasc Med; 2001; 1(1):61-70. PubMed ID: 15199515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.
    Duhl AJ
    J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer and thromboembolism: from biology to clinics.
    Castelli R; Porro F
    Minerva Med; 2006 Apr; 97(2):175-89. PubMed ID: 16760856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of low molecular weight heparins on venous thromboembolism and survival in patients with cancer.
    Lee AY
    Thromb Res; 2007; 120 Suppl 2():S121-7. PubMed ID: 18023705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.